Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Nature Reviews. Nephrology
|
January 30, 2019
C3 glomerulopathy - understanding a rare complement-driven renal disease
Richard J H Smith, Gerald B Appel, Anna M Blom, et al.
Plos Pathogens
|
November 8, 2012
Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules
Steven Johnson, Lionel Tan, Stijn van der Veen, et al.
American Journal of Nephrology
|
November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
Steven D Podos, Howard Trachtman, Gerald B Appel, et al.
Immunity
|
February 24, 2017
Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation
Bertrand Calippe, Sebastien Augustin, Fanny Beguier, et al.
Immunity
|
July 27, 2023
Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis
Máté G Kiss, Nikolina Papac-Miličević, Florentina Porsch, et al.
American Journal of Nephrology
|
November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies
Carla Nester, Gerald B Appel, Andrew S Bomback, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 23, 2021
C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes
Edwin K S Wong, Kevin J Marchbank, Hannah Lomax-Browne, et al.
Journal of the American Society of Nephrology : JASN
|
May 6, 2024
Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy
Marie-Sophie Meuleman, Florent Petitprez, Matthew C Pickering, et al.
Elife
|
March 11, 2021
Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death
Jack Gisby, Candice L Clarke, Nicholas Medjeral-Thomas, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group
Carla Nester, Dima A Decker, Matthias Meier, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Nature Reviews. Nephrology
|
January 30, 2019
C3 glomerulopathy - understanding a rare complement-driven renal disease
Richard J H Smith, Gerald B Appel, Anna M Blom, et al.
Plos Pathogens
|
November 8, 2012
Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules
Steven Johnson, Lionel Tan, Stijn van der Veen, et al.
American Journal of Nephrology
|
November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
Steven D Podos, Howard Trachtman, Gerald B Appel, et al.
Immunity
|
February 24, 2017
Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation
Bertrand Calippe, Sebastien Augustin, Fanny Beguier, et al.
Immunity
|
July 27, 2023
Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis
Máté G Kiss, Nikolina Papac-Miličević, Florentina Porsch, et al.
American Journal of Nephrology
|
November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies
Carla Nester, Gerald B Appel, Andrew S Bomback, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 23, 2021
C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes
Edwin K S Wong, Kevin J Marchbank, Hannah Lomax-Browne, et al.
Journal of the American Society of Nephrology : JASN
|
May 6, 2024
Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy
Marie-Sophie Meuleman, Florent Petitprez, Matthew C Pickering, et al.
Elife
|
March 11, 2021
Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death
Jack Gisby, Candice L Clarke, Nicholas Medjeral-Thomas, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group
Carla Nester, Dima A Decker, Matthias Meier, et al.
Page
of 14